• AXIS Clinicals successfully completes 20th US FDA audit (April 2017)
  • AXIS Clinicals successfully completes MCC South Africa audit (March 2017)
  • AXIS Clinicals successfully completes GCC audit (February 2016)
  • AXIS Clinicals successfully completes 7th ANVISA – Brazil audit (March 2015)
  • AXIS Clinicals successfully completes WHO audit (March 2015)
  • AXIS Clinicals successfully completes 3rd MHRA audit (Sep 2014)
  • BA-BE studies conducted at AXIS Clinicals are accepted by Chile – ISP

Your Preferred Partner of Choice - WHY?

  • Speed

We will speed you to the next milestone, while avoiding bumps in the road. Because the faster you reach each milestone, the faster your compound can be advanced to the next stage

  • Quality

We are passionate about what we do and want our name to stand for Excellence. We are determined to be an example that industry aspires to follow

  • Customer Focus

We build long lasting, collaborate relationships with our customers and work with them as thought partners

  • Disciplined Timelines

We value the importance of time and adhere to our commitments

 

Fact sheet

  • 2,400+ clinical studies completed since inception
  • 350+ bioanalytical methods developed
  • 50+ successful Regulatory audits
  • Global footprint of operations with sites in India, U.S & Mexico.
  • Two clinical facilities (Hyderabad & Ahmedabad) in India
  • 100+ National and International Pharma/Biotech Sponsor companies working with AXIS
  • US FDA : 500+ approvals, EMEA : 100+ approvals, Canada : 50+ approvals, Australia : 50+ approvals
  • 500+ experianced employees working globally
  • Huge database of patient population in various therapeutic areas viz. Cardiology, Opthalmology, Schizophrenia, Diabetology, Oncology. Orthopedics etc..

Copyright Axis Clinicals - All Rights Reserved